ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,184Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 1844

$487K Total Retail Price of All Prescriptions

Rank: 377 out of 1844

287 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,901 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCHLOROTHIAZIDE 416 366 1 9
LISINOPRIL 389 331 2 4
PRAVASTATIN SODIUM 349 260 3 10
METOPROLOL SUCCINATE 303 287 4 14
FUROSEMIDE 290 247 5 7
LEVOTHYROXINE SODIUM 281 272 6 1
SIMVASTATIN 281 260 6 3
AMLODIPINE BESYLATE 272 226 8 6
WARFARIN SODIUM 272 237 8 13
OMEPRAZOLE 236 216 10 5
ATENOLOL 197 171 11 17
METOPROLOL TARTRATE 172 132 12 11
ALLOPURINOL 153 135 13 29
ENALAPRIL MALEATE 149 109 14 69
LOSARTAN POTASSIUM 146 121 15 24
LANTUS 145 115 16 42
METFORMIN HCL 128 79 17 8
ALENDRONATE SODIUM 126 114 18 25
RANITIDINE HCL 118 79 19 38
ATORVASTATIN CALCIUM 112 97 20 12
POTASSIUM CHLORIDE 110 93 21 16
TRAMADOL HCL 110 104 21 18
FENOFIBRATE 98 85 23 71
HYDROCODONE-ACETAMINOPHEN 94 76 S3 24 2
SPIRONOLACTONE 91 64 25 60
CARVEDILOL 91 69 25 22
DONEPEZIL HCL 90 90 27 26
TAMSULOSIN HCL 90 88 27 27
KLOR-CON M20 85 50 29 54
DIOVAN 84 68 30 58
SERTRALINE HCL 82 81 31 21
GLIPIZIDE ER 73 62 32 79
AZITHROMYCIN 72 61 33 37
FLUOXETINE HCL 69 69 34 41
PANTOPRAZOLE SODIUM 69 67 34 32
GLIPIZIDE 69 57 34 70
GABAPENTIN 68 60 37 15
INSULIN SYRINGE 67 59 38 111
DILTIAZEM 24HR ER 65 54 39 146
CLOPIDOGREL 64 64 40 34
CEPHALEXIN 64 48 40 56
TRIAMTERENE-HCTZ 60 60 42 48
NEXIUM 59 35 43 31
PLAVIX 58 58 44 61
CIPROFLOXACIN HCL 51 48 45 62
KLOR-CON 10 51 51 45 123
HUMALOG 50 34 47 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.